Drug Approval | April 17, 2026
Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden
The national platform brought together healthcare professionals, patient advocates, and stakeholders
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
Visit underscores push for self-reliance in essential medical consumables and India’s ambition to become a global medtech manufacturing hub
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
Research by NITI Aayog and All India Institute of Medical Sciences has shown that at least 30% of trauma deaths are linked to delays in emergency response
This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
Subscribe To Our Newsletter & Stay Updated
